Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 70625-207

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 70625-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sungen Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000mg-500ct (1000mg 500ct)

Label for Ranolazine Extended-Release Tablets, 1000 mg strength, film-coated, extended-release oral tablets. The label indicates a package size of 500 tablets. Distributed by Praxgen Pharmaceuticals LLC, Princeton, NJ. It includes storage instructions and states the tablets should not be crushed, broken, or chewed.*

FDA Label Image

1000mg-60ct (1000mg 60ct)

Ranolazine Extended-Release Tablets 1000 mg film-coated oral tablets in a 60-tablet bottle, labeled for prescription use only. The label states to swallow whole without crushing or chewing. Distributed by Praxgen Pharmaceuticals LLC, Princeton, NJ. Storage instructions and dosage guidance references are noted on the label.*

FDA Label Image

500mg-500ct (500mg 500ct)

Ranolazine Extended-Release Tablets 500 mg film-coated oral tablets, packaged in a bottle of 500. The label includes storage instructions, dosage guidance referral, and distributor information for Praxgen Pharmaceuticals LLC. The product is labeled as prescription-only and specifies not to crush, break, or chew the tablets.*

FDA Label Image

500mg-60ct (500mg 60ct)

Ranolazine Extended-Release Tablets label showing 500 mg strength in a 60 tablet bottle. The label instructs swallowing whole without crushing, breaking, or chewing. It includes storage conditions and is distributed by Praxgen Pharmaceuticals LLC, Princeton, NJ. The label also features a barcode and revision date 02/2021.*

FDA Label Image

Structure (Structure)

Chemical structure of Ranolazine, showing its molecular framework with aromatic rings, amide, ether, hydroxyl, and methoxy functional groups as part of the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.